STOCKWATCH
·
Pharmaceuticals
Deals9 Apr 2025, 10:01 pm

Fredun Pharmaceuticals Secures Tender from TNMSC for Supply of Generic Pharma Products Worth Rs. 150-180 Million

AI Summary

Fredun Pharmaceuticals Ltd has secured a tender from Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines. The total value of the tender ranges between Rs. 150 million and Rs. 180 million. The supply of these goods is set to commence within the first quarter of FY26 and will extend over a period of 14 months. This development underlines Fredun Pharma’s commitment to providing high-quality and affordable healthcare solutions to the community.

Key Highlights

  • Fredun Pharmaceuticals has secured a tender from Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines.
  • The total value of the tender is between Rs. 150 million and Rs. 180 million.
  • The supply of goods will commence within the first quarter of FY26 and will extend over a period of 14 months.
  • This deal underlines Fredun Pharma’s commitment to providing high-quality and affordable healthcare solutions.
  • The products will be part of the Fredun Gx brand, which is known for its dedication to excellence and reliability.
FREDUN
Pharmaceuticals
Fredun Pharmaceuticals Ltd

Price Impact